| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/16/2002 | US6420115 Monitoring binding activities of nuleotide sequences; obtain nucleotide sequences, incubate with probes, detect intensity of bound cmplex |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6420112 DNA attachment to support structures |
| 07/16/2002 | US6420111 Multiplex VGID |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6420109 Nucleic acid ligand interaction assays |
| 07/16/2002 | US6420108 Computer-aided display for comparative gene expression |
| 07/16/2002 | US6420106 Diagnosing uterine cancer in humans; obtain sample tissue, monitor viral nucleic acid concentration, amplified viral concentration indicates uterine canccer |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419824 Apparatus and method for separating and purifying polynucleotides |
| 07/16/2002 | US6419361 Spectral bio-imaging of the eye |
| 07/16/2002 | CA2148537C Stable freeze-dried formulation comprising a protein; assay kit |
| 07/16/2002 | CA2124580C Method for selecting recombinant microorganisms containing at their surface at least one molecule having enzymatic activity |
| 07/11/2002 | WO2002054450A2 Method of patterning a mask on the surface of a substrate and product manufactured thereby |
| 07/11/2002 | WO2002054078A2 Method for determining skin ageing in vitro |
| 07/11/2002 | WO2002054073A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | WO2002054072A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 07/11/2002 | WO2002054070A1 Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
| 07/11/2002 | WO2002054068A1 Method of reusing dna-immobilization substrate |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002054055A1 Biosensors having improved sample application |
| 07/11/2002 | WO2002054054A1 Biosensor |
| 07/11/2002 | WO2002054044A2 Focused acoustic ejection cell sorting system and method |
| 07/11/2002 | WO2002053780A2 5'-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms |
| 07/11/2002 | WO2002053779A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 07/11/2002 | WO2002053778A2 Method for relative quantification of attached nucleic acids |
| 07/11/2002 | WO2002053777A2 Device and method for tracking conditions in an assay |
| 07/11/2002 | WO2002053776A1 Gene amplification detection using fluorescence polarisation |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053774A2 Method for determining homeostasis of the skin |
| 07/11/2002 | WO2002053773A2 Method for determining skin stress or skin ageing in vitro |
| 07/11/2002 | WO2002053772A1 Novel biosensor system |
| 07/11/2002 | WO2002053771A2 Detection of pathogenic bacteria |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053769A2 Dna chip for performing causal diagnosis of hypertension |
| 07/11/2002 | WO2002053768A2 Dna rapid immune detection methods and apparatus |
| 07/11/2002 | WO2002053767A1 Marker, forgery detection agent, method of real/forgery discrimination for product, method of preventing forgery distribution, and product |
| 07/11/2002 | WO2002053766A1 Method for determining the enzyme activity of sugar hydrolases |
| 07/11/2002 | WO2002053764A2 Hydrophilic polymeric material for coating biosensors |
| 07/11/2002 | WO2002053763A2 Radiofrequency radiation detection employing microorganisms |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053724A2 Enzymatic deprotection of amines and hydroxides |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053712A2 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | WO2002053706A1 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pylori and escherichia coli 157:h7 |
| 07/11/2002 | WO2002053705A1 Culture medium for detecting bacteria of listeria genus |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053592A1 Novel polypeptide and dna thereof |
| 07/11/2002 | WO2002053579A2 Haplotypes of the fmo2 gene |
| 07/11/2002 | WO2002053575A1 Drug target isogenes: polymorphisms in the lecithin-cholesterol acyltransferase gene |
| 07/11/2002 | WO2002053569A1 Method of assaying lysophospholipase d activity |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053018A2 Method of detecting polymorphisms associated with breast carcinoma in mhc genes |
| 07/11/2002 | WO2002053017A2 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 07/11/2002 | WO2002053016A2 Compounds and methods for the diagnosis and treatment of babesia infection |
| 07/11/2002 | WO2002052936A1 Preserving agents for freeze-dried cells |
| 07/11/2002 | WO2002038731A3 Method for measuring nucleotides |
| 07/11/2002 | WO2002036621A8 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 07/11/2002 | WO2002033125A8 Nucleic acid detection by dendrimeric labeling |
| 07/11/2002 | WO2002032288A3 Cd38 modulated chemotaxis |
| 07/11/2002 | WO2002030354A3 Uridine therapy for patients with elevated purine levels |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002027019A8 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 07/11/2002 | WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 07/11/2002 | WO2002020728A3 High growth methanotrophic bacterial strain methylomonas 16a |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2001096580A3 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 07/11/2002 | WO2001094643A3 Powdery mildew resistant plants |
| 07/11/2002 | WO2001094550A3 Identification and use of molecular markers indicating cellular reprogramming |
| 07/11/2002 | WO2001094548A3 Hy2 family of bilin reductases |
| 07/11/2002 | WO2001090123A3 Haplotypes of the agtrl1 gene |
| 07/11/2002 | WO2001084153A3 Diagnostic device with multiple independent flow paths |
| 07/11/2002 | WO2001081917A3 Chemical signal enhancement of dynamic intensity-based intracellular protein- and fluorophore-based redistribution assays for drug screening |
| 07/11/2002 | WO2001081616A3 Method for screening of microorganisms under nutrient limited conditions |
| 07/11/2002 | WO2001081412A3 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001042510A3 Method for selectively isolating a nucleic acid |
| 07/11/2002 | WO2001040516A3 Generation of single-strand circular dna from linear self-annealing segments |
| 07/11/2002 | WO2001040507A3 Method for detecting and evaluating a potentially aberrantly methylated dns region on the x chromosome or the clonality |
| 07/11/2002 | WO2001038576A3 Human single nucleotide polymorphisms |
| 07/11/2002 | WO2001036661A3 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 07/11/2002 | WO2001032920A3 Agents implicated in endometriosis |
| 07/11/2002 | WO2001032916A3 Automated lysophospholipid assay and methods of detecting cancer |
| 07/11/2002 | WO2001032911A3 Toxicity assay using pva-immobilised luminescent bacteria |
| 07/11/2002 | WO2001031580A3 Methods and devices for identifying patterns in biological systems |